Autologous cytotoxic T lymphocytes targeting melanoma cells from a patient with a favorable clinical course were generated and the gene encoding one of the targeted tumor antigens was cloned and named MAGE1 [10,12]. The gene discussed is MAGEA1; the disease is neoplasm.